Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY
The Vanguard Group reported a 10.03% stake in Alnylam Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 7, 2025
The Vanguard Group reported a 10.03% stake in Alnylam Pharmaceuticals, Inc., 13,056,605 shares, as a passive investor on Mar 31, 2025. Filed Apr 7, 2025 (Schedule 13G/A).
- Stake
- 10.03%
- Shares
- 13,056,605
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.03% | 13,056,605 |
Source
Related
- Alnylam Pharmaceuticals, Inc.
- The Vanguard Group
- Alnylam Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Supran Bryan · Oct 6, 2026
- Form 4 · Greenstreet Yvonne · Sep 22, 2026
- Form 4 · Pyott David E I · Jun 3, 2026
- Form 4 · Sigal Charles Elliott · May 22, 2026
- Form 4 · Amy Schulman · May 22, 2026